From Name:
From Email:
To Name:
To Email:

Optional Message:

Neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma

from Clinical Transplantation (subscription required)

Transarterial chemoembolization (TACE) has gained wide acceptance as a bridge to liver transplantation (LT) in patients with hepatocellular carcinoma (HCC). A recent analysis compared long-term results with and without neoadjuvant TACE and to identify subgroups, which particularly benefit from TACE. Results suggest that TACE lowers the HCC recurrence rate in patients inside the Milan and UCSF criteria. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063